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Abstract: Background: Antibiotic resistance has become a growing global problem where over-
prescription is a contributing factor for its development. In the endodontics field, complementary
treatments, such as antimicrobial photodynamic therapy (aPDT), have been described to eliminate
residual bacteria from the root canal space and reduce complications. The aim of this review is to
describe the literature evidence up to now regarding the advantages, efficiency, and clinical outcomes
of this therapy in endodontics as a possible tool to combat antibiotic resistance. Methods: A review
of the literature from 2010 to 2021 was carried out using the PubMed and Web of Science databases.
Two steps were taken: First, articles were compiled through the terms and MeSH terms “Photochesd-
motherapy” and “endodontics.” Then, a second search was conducted using “photodynamic therapy”
and “antibiotic resistance” or “drug resistance, microbial.” Results: A total of 51 articles were in-
cluded for evaluation: 27 laboratory studies, 14 reviews, and 10 clinical studies. Laboratory studies
show that aPDT achieves significant bacterial elimination, even against antibiotic-resistant species,
and is also effective in biofilm disruption. Clinical studies suggest that aPDT can be considered
a promising technique to reduce bacterial complications, and reviews about the issue confirm its
advantages. Conclusion: The benefits of aPDT in reducing complications due to its antibacterial
effects means a possible decrease in systemic antibiotic prescription in endodontics. In addition, it
could be an alternative to local intracanal antibiotic therapy, avoiding the appearance of possible
antibiotic resistance, as no bacterial resistance with aPDT has been described to date.
Keywords: photodynamic therapy; antimicrobial photodynamic therapy; antibiotic resistance; en-
dodontics; dentistry
1. Introduction
The challenge of a successful outcome in root canal treatment, apart from the anatomi-
cal variations of the root canal systems, the tooth position, presence of calcified canals or
pulp stones, and patient related factors, is the variety of bacterial strains that can be found
in endodontic infections, such as Streptococci, Peptostreptococcus, Lactobacilli, Propionibac-
terium, Actinomyces, Eubacterium, Veillonella parvula, Bacteroides, and Fusobacterium, among
others [1]. In addition, microbial contamination of the root canal system is not limited to
the pulp tissue space, but can also penetrate the dentinal tubules up to a depth of 1000 µm,
as well as accessory canals, anastomoses, and the apical complex anatomy. This makes
adequate decontamination difficult with the classical treatment based on chemomechanical
disinfection (CMD) together with irrigation solutions, with sodium hypochlorite (NaOCl)
being the irrigant of choice during the procedure [2–4].
Following the literature evidence, the use of antibiotics in conjunction with the en-
dodontic treatment is indicated in cases of an acute apical abscess when the patient has
underlying medical complications or if the patient is healthy, but the infection shows signs
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of systemic involvement such as fever or swelling. Antibiotics are also indicated in cases of
infections with a rapid onset (acute phase development in less than 24 h) and in spreading
infections that cause cellulitis or osteomyelitis. In addition, they can be administered in
persistent infections when all local measures and intracanal medications fail to resolve
the infection. On the contrary, dentists should not prescribe antibiotics for symptomatic
irreversible pulpitis, pulp necrosis, acute apical periodontitis, or chronic apical abscess [5].
Antibiotic administration is usually empirical, based on epidemiological data. Broad-
spectrum amoxicillin is the most commonly used, although other practitioners prefer the
combination of amoxicillin and clavulanic acid because of the low bacterial resistance to
this combination [6–8].
Prescription by dentists represents 10% of all antibiotics prescribed by health care
professionals [9,10], and their use is increasing, sometimes in the absence of indication,
according to the current scientific evidence. This contributes to the serious public health
problem of bacterial resistance to antibiotics, such as the examples seen in cephalosporins
and fluoroquinolones, resulting in the development of the methicillin-resistant Staphylo-
coccus aureus resistant to a full range of antibiotics [11]. It is estimated that by 2050, there
could be up to 10 million annual deaths caused by infections that could have been easily
cured before resistance if adequate global measures are not taken [12].
One of the complementary therapies in endodontics described as a photo-disinfection
technique is photodynamic therapy (PDT); specifically, antimicrobial photodynamic ther-
apy (aPDT). It has other wide therapeutic indications in dentistry, mostly in periodontitis
and peri-implant diseases, as well as in the treatment of some oral lesions (lichen planus,
candidiasis, lesions induced by human herpes viruses such as recurrent herpes labialis).
PDT may also have an indication in the treatment of alveolar osteitis and post-extraction
pain [13].
The aPDT mechanism is based on the interaction between a specific wavelength
light source and a photosensitizer (PS) (nontoxic natural or synthetic chemical solution,
usually a dye applied locally to the target tissues) in the presence of oxygen to induce
specific cell damage. There are two ways the PS can react with the biomolecule. The type
I reaction, or electron transfer reaction, results in the formation of highly reactive free
radicals by removing the electron/hydrogen molecule from the substrate, which then react
with the endogenous oxygen molecule, producing reactive oxygen species (ROS) such as
hydrogen peroxide, hydroxyl radicals, and superoxide. This reaction causes irreversible cell
damage [14,15]. As for the type II reaction, the PS reaches a triple excited state, reacts with
the oxygen molecules present at the target cells such as Gram-positive and Gram-negative
bacteria, and produces a highly reactive oxygen or singlet oxygen (1O2) molecule, which
leads to microbial cell death by oxidative damage. This affects their plasma membrane,
including proteins, lipids, and DNA, without affecting host cell viability [16]. The reactive
oxygen singlets have a very short half-life (<0.04 µs) and action ratio (0.02 µm), making
their effect very brief and localized. The type II reaction is the most used for combating
infections (Figure 1) [17]. This entire process described with aPDT eliminates bacteria in a
planktonic state and in biofilms, acting on extracellular biofilm molecules (polysaccharides
in the extracellular matrix) by the singlet oxygen released from a photodynamic reaction.
The wavelength used to irradiate the PS is chosen based on the coefficient of absorption
of the PS. The corresponding wavelengths described in the literature are 620–700 nm
with toluidine blue and methylene blue, 600–805 nm with cyanine, 620–650 nm with
hematoporphyrins, 300–500 nm (ultraviolet/blue light) with curcumin and its derivatives,
and 660–700 nm with the hytalocyanines [13].
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The aim of this review is to provide a summary of what we know until now about
PD in relation to endo ontics, where the use of antibiotics is a common practice, and if
PDT can be an efficient therapy to improve clinical outcomes, reduce complications, and,
subsequently, limit antibiotics prescription.
2. Materials and Methods
A literature sea ch was performed in the Web of Science (WOS) and PubMed databases
in 2 steps. In the first search, the following terms were used in WOS: ALL = (photody amic
therapy or photo hemotherapy r PDT or aPDT) AND ALL = (endod ntics or “root canal
therapy” or “root canal reatment”) and for PubMed: (“Endodontics” (MeSH)) AND
“Photochemotherapy” (MeSH).
The second st p wa carried out in WOS with the search criteria ALL = (photodynamic
therapy or photochemotherapy or PDT or aPDT) AND ALL = (antibiotic resistance) AND
ALL = (dentistry) and in PubMed with the MeSH terms (“Photochemotherapy” (MeSH))
AND “Drug Resistance, Microbial” (MeSH).
We included studies that were published from the year 2010 to 2021, in the English
language, in vitro and ex vivo studies that compared the effect of PDT in endodontics to
other techniques, clinical studies in permanent dentition with mature apices evaluating
the disinfection effect of PDT in endodontics, and review articles. Animal studies were
excluded and not considered for this review.
3. Results
A total of 51 articles were included for evaluation: 27 laboratory studies, 14 reviews,
and 10 clinical studies. Data extraction from the included clinical studies is summarized in
Table 1, specifying the main author, year of publication, study design, sample size (n), study
groups, endodontic pathology to be treated, method of outcome evaluation, follow-up, and
clinical outcome reported.
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4. Discussion
The treatment of acute endodontic infection depends on local microbial reduction
by CMD of the root canal space and drainage of the periapical tissue exudate. This
local treatment should be sufficient in the absence of additional complications; however,
dental practitioners have shown a tendency to overprescribe systemic antibiotics when
unnecessary [5]. Some authors surveyed antibiotic prescription habits in the endodontic
field around different regions. Silva et al. [18], in a cross-sectional study in Portugal,
reported its use by 16–44% of dentists in cases of irreversible pulpitis, 15.8–41.1% in
necrotic pulps, and 45% in cases with chronic sinus tract related to the infected tooth.
In Belgium, Mainjot et al. [19], described antibiotic prescription in the absence of fever
by 92.2% of dental professionals, and 54.2% did not perform any local dental treatment
after prescription. Members of the Spanish Endodontic Society (AEDE) responded in a
survey that they administered antibiotics in 40% of irreversible pulpitis cases and in 53%
of necrotic pulps and acute apical periodontitis without swelling [20]. Dormoy et al. [21]
surveyed French dentists for the first time to study nonclinical factors that influence
antibiotics prescription. Although dentists were aware of the antibiotic resistance public
health problem, sometimes they were guided by nonobjective clinical criteria to reassure
themselves or their patients. These examples show the lack of adherence to the scientific
evidence during the antibiotic prescription protocols in endodontics, which collaborate in
the development of antibiotic resistance.
Bacterial resistance is based on gene changes, and some authors have associated this
drug resistance problem with persistent endodontic infections caused by species such as
Prevotella spp., which is B-lactamase positive, or E. faecalis [22–24]. In their clinical study,
Jungermann et al. [25], identified selected antibiotic bacteria resistance genes performing
a polymerase chain reaction of teeth samples with primary and persistent endodontic
infection before and after contemporary chemomechanical preparation and medication
with calcium hydroxide inside the root canals. They observed the prevalence of beta-
lactam resistance genes (blaTEM-1) in primary endodontic infections that was significantly
reduced after treatment, whereas tetracycline resistance genes (tetM) found in both primary
and persistent endodontic infections were resistant to the endodontic treatment.
To avoid this problem, the use of local application techniques to eliminate residual
bacteria from the root canal space have been described, such as the use of local triple an-
tibiotic paste combining ciprofloxacin, metronidazole, and minocycline that can efficiently
reduce bacteria but with the risk of developing antimicrobial resistance [26], aPDT has
also been investigated in the endodontic field for its promising antimicrobial action. In an
in vitro study, Camacho-Alonso et al. [27] compared the antimicrobial effect of triple antibi-
otic paste, 2% chlorhexidine, ozone therapy, and aPDT and showed significant bacterial
reduction in all of them compared with the control group.
Focusing on aPDT, its correct clinical application depends on many factors, such as
the pre-irradiation time (time elapsed between the dye application and the beginning of
photoactivation), light source power density and duration, PS concentration, wettability to
the root canal walls, and oxygen presence at the target cells.
The most commonly used PS in endodontic studies is phenothiazine salts such as
toluidine blue (TBO) or methylene blue (MB) because of their amphiphilic nature (both
hydrophilic and hydrophobic), which facilitates the staining of both Gram-negative and
Gram-positive bacteria responsible for most endodontic infections [28]. PS concentrations
described in the literature range from 6.25 to 25 µg/mL for MB and from 10 to 100 µg/mL
for TBO [29]. After root canal preparation, PS should be delivered inside the root canal
and left in place for 60 s to give time for bacterial staining, and then irradiated for 30 s.
Pourhajibagher et al. [30] applied this protocol to eliminate high concentrations of bacteria,
and Kosareih et al. [31] reported better dentinal tubule penetration by the PS when the root
canal was previously irrigated with 17% EDTA for 2 min.
The corresponding wavelengths activating the light sources for these PS are 630 nm
for TBO and 660 nm for MB [32]. Regarding the light source application, Nunes et al. [33]
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showed that the application is equally effective whether or not an optical fiber is inserted
inside the root canal during the photoactivation process.
In relation to power settings, the literature shows a range of heterogeneous parameters
between 40 mW and 100 mW with an exposure time from 60 to 240 s [34–36].
The success of endodontic therapy can reach 94% when a negative culture is obtained
from the root canal prior to obturation [37], so one of the main challenges in endodontic
infections is combating the presence of multispecies bacteria attached to the surfaced of the
root canal, forming a biofilm.
This biofilm disruption inhibits the transfer of antibiotic resistance genes among bac-
teria and interferes with bacterial colonization [17]. Additionally, up to now, we did not
find any report of bacterial resistance to aPDT. This can be attributed to its nonspecific
mechanism of action by the oxygen singlet, which reacts against several cell components,
unlike the key-lock principle of antibiotics in which bacterial mutation can modify their
susceptible receptors [29]. Nevertheless, some authors [38,39] attempted to develop aPDT
resistance by repeated sub-lethal doses and the regrowth of microorganisms and by re-
peated cycles of partial inactivation, but with no success.
In an in vitro study, López Jiménez et al. [40] compared the effect of different dyes
(TBO and MB) and light sources (diode laser 670 nm and LED 628 nm) alone or in combina-
tion on biofilms with Enterococcus faecalis. The use of light therapy alone or in combination
with the dyes altered the biofilm topography, such as bacterial wall destruction, loss of cell
morphology, or leakage of the intracellular contents, whereas the dyes alone did not induce
morphological changes. Additionally, bacterial surface roughness increased after treatment
by the same combination therapy groups (TBO with 628 nm and MB with 670 nm).
Some authors optimized the PS biofilm penetration capacity and increased its affin-
ity to bacterial cell membrane by combining it with rose bengal-functionalized chitosan
nanoparticles [41,42]. Afkhami et al. [43] showed better biofilm penetration using a diode
laser with silver nanoparticles and indocyanine green.
In their review, Cieplik et al. [44] stated the benefits of aPDT to deactivate biofilms and
highlighted its promising effects. However, most of the laboratory studies used different
experimental biofilm models with different culture protocols, resulting in heterogeneous
studies difficult to compare.
Ex vivo laboratory studies tried to reproduce the clinical scenario of a multispecies
biofilm using necrotic pulps. Ng et al. [45] compared microbiological samples from necrotic
root canals of recently extracted human teeth before and after treatment with CMD alone or
in combination with aPDT and reported significant bacterial reduction after aPDT application,
with lower bacterial concentrations in dentinal tubules at a depth up to 485 µm.
The superior aPDT results were also confirmed by Hoedke et al. [46] in another ex
vivo experiment detecting more bacterial reduction belonging to a planktonic and adherent
bacterial multispecies biofilm in root canals after CMD combined with 2% chlorhexidine
and aPDT, even after 5 days of further incubation.
To date, there have been few recent clinical trials on aPDT in relation to the endodontic
field, although those that we reviewed show a promising tendency to obtain better results
with the aPDT approach in addition to the conventional CMD (Table 1).
In a quasi-controlled study on endodontically treated teeth with persistent infection,
Garcez et al. [47] took three bacterial culture samples from each tooth, the first one after
accessing the root canal space and comparing it with another culture after CMD and with a
final one following aPDT.
The first microbiological sample confirmed the presence of at least one microorganism
resistant to antibiotics of Enterococcus sp., Prevotella sp., Actinomyces sp., Peptostreptococcus
sp., Streptococcus sp., Fusobacterium sp., Porphyromonas sp., Enterobacter sp., and Propi-
onibacterium sp., and with different degrees of antimicrobial resistance to erythromycin,
ampicillin, penicillin G, vancomycin, cephalosporin, clindamycin, chloramphenicol, and
tetracycline. The aPDT completely eliminated the microbial load of all 30 teeth, proving
the efficacy of this approach toward drug-resistant bacteria found in persistent infections.
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Zorita-García et al. [48] in a microbiological clinical study in forty-two single rooted
necrotic posterior teeth obtained three samples from the same tooth. In the initial sample
taken after accessing the root canal, a mean value of 113.5 ± 130 colony forming units
(CFU) per tooth was detected. After CMD, the mean CFU per tooth decreased to 26.52 ± 72,
which was even more reduced in the third sample after aPDT to 4.2 ± 13 CFU/tooth.
aPDT application in endodontic periapical surgery was also evaluated by the same
author in a clinical study [49]. After cleaning the surgical area and preparing the root end
for sealing, a microbiological culture was taken to compare it to another culture obtained
after aPDT application. A mean bacterial reduction of 1.5 log was reported, indicating
its additional benefits over conventional surgery alone. The author reported periapical
healing of 78% in a 3-year follow-up period. However, the culture-based analysis has low
sensitivity and can fail to detect culture-difficult, or yet, uncultured bacteria.
Based on this study, Vieira et al. [50] improved the microbiological detection method
using a quantitative real-time polymerase chain reaction (qPCR) in a case series study on
16 patients with 19 teeth programmed for periapical surgery. They found a significant
reduction in total bacterial and streptococci levels after applying aPDT and reported high
healing rates with a mean follow-up of 16 months.
Abu Hasna et al. [51] used aPDT as an adjunctive disinfection technique to manage
a failing symptomatic endodontically treated tooth due to root perforation near the apex.
They used aPDT during endodontic retreatment to remove all residual bacteria from the
root canal space before obturation, as well as during the apicoectomy surgery on the same
tooth to disinfect the surgical area before root end sealing. The apical area was obturated
with bioceramic cement, and the bone defect was bone grafted. A twelve-month follow-up
using 3D cone beam computed tomography in the treated area showed complete healing
with neobone formation, indicating a successful outcome.
Moreira et al. [52] reported, in two cases of failed endodontic retreatments, the pos-
sibility of applying seven to ten sessions of aPDT via the sinus tract to avoid surgical
intervention and antibiotic prescription, where both cases showed the complete healing of
the sinus tract with a periapical bone repair and they were asymptomatic.
Efficient microbial eradication reduces healing time and offers better clinical outcomes,
as shown in a randomized controlled clinical trial by De Miranda et al. [53]. They treated
necrotic teeth with aPDT in the experimental group, where they observed better healing
and lower periapical index (PAI) scores at the 6-month follow-up. Nevertheless, longer
follow-up periods are recommended to reach a more reliable conclusion.
Conejero et al. [54] in a retrospective clinical study analyzed two groups. The group
where aPDT was applied as an adjunctive therapy showed a shorter periapical healing
time (15 ± 9.33 months) compared to conventional CMD alone (20.35 ± 22.1 months).
The superior bacterial elimination is in accordance with the randomized controlled
clinical trial by Rabello et al. [55] that evaluated the antimicrobial effect of aPDT in one-visit
versus two-visit cases, with calcium hydroxide intracanal medication between appoint-
ments. They described the existence of a significant bacterial reduction in one-visit cases
with aPDT but no further benefits in the two-visit approach. The effectiveness of a single-
visit approach using aPDT was confirmed by the randomized controlled clinical trial by
Asnaashari et al. [56] in endodontic retreatment cases, concluding even a superior microbio-
logical eradication after applying aPDT in one session versus a calcium hydroxide dressing
in two sessions. The ability to perform endodontic treatment in a single visit permits an
immediate coronal restoration, which reduces the possible bacterial contamination from
the oral flora during the 2-week waiting period of the two-visit approach.
5. Conclusions
Our review projects the bacterial resistance problem focusing on the endodontic field
and the challenges of persistent infections with antimicrobial-resistant strains. Antibiotic
prescription should be conducted with caution after an adequate evaluation of the clinical
situation to avoid overprescription.
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Local aPDT treatment showed a promising tendency toward significant bacterial
elimination, which has also proven effective in biofilms disruption. This adjunctive therapy
can improve the clinical outcome, increasing the success rate in conventional and surgical
endodontic procedures due to its efficient elimination of resistant bacteria. Therefore, it
could avoid the appearance of endodontic complications that involve the use of a systemic
antibiotic prescription. In addition, it could be an alternative to local intracanal antibiotic
therapy, avoiding possible antibiotic resistance.
This therapy seems to be safe and predictable, and the literature reported no resistance
toward it to date. More high-evidence clinical trials are needed with long-term follow-up
to confirm the superiority of aPDT as an adjunctive tool and spread its use among dentists.
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5. Segura-Egea, J.J.; Gould, K.; Şen, B.H.; Jonasson, P.; Cotti, E.; Mazzoni, A. Antibiotics in Endodontics: A review. Int. Endod. J.
2017, 50, 1169–1184. [CrossRef] [PubMed]
6. Vallano, A.; Izarra, A. Principios de terapéutica antimicrobiana. Medicine 2006, 9, 3196–3203. [CrossRef]
7. Marra, F.; George, D.; Chong, M.; Sutherland, S.; Patrick, D.M. Antibiotic prescribing by dentists has increased: Why? J. Am. Dent.
Assoc. 2016, 147, 320–327. [CrossRef]
8. Maestre-Vera, J.R. Opciones terapéuticas en la infección de origen odontogénico. Med. Oral. Patol. Oral. Cir. Bucal. 2004, 9, 19–31.
9. Epstein, J.B.; Chong, S.; Le, N.D. A survey of antibiotic use in dentistry. J. Am. Dent. Assoc. 2000, 131, 1600–1609. [CrossRef]
10. Pallasch, T.J. Global antibiotic resistance and its impact on the dental community. J. N. J. Dent. Assoc. 2000, 71, 14–15.
11. Takasaki, A.A.; Aoki, A.; Mizutani, K.; Schwarz, F.; Sculean, A.; Wang, C.Y. Application of antimicrobial photodynamic therapy in
periodontal and peri-implant diseases. Periodontology 2000, 51, 109–140. [CrossRef]
12. De Kraker, M.E.; Stewardson, A.J.; Harbarth, S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS
Med. 2016, 13, e1002184. [CrossRef]
13. Gursoy, H.; Ozcakir-Tomruk, C.; Tanalp, J.; Yilmaz, S. Photodynamic therapy in dentistry: A literature review. Clin. Oral. Investig.
2013, 17, 1113–1125. [CrossRef] [PubMed]
14. Javed, F.; Romanos, G.E. Does photodynamic therapy enhance standard antibacterial therapy in dentistry? Photomed. Laser Surg.
2013, 31, 512–518. [CrossRef]
15. Gluckman, J.L. Hematoporphyrin photodynamic therapy: Is there truly a future in head and neck oncology? Reflections on a
5-year experience. Laryngoscope 1991, 101, 36–42. [CrossRef] [PubMed]
16. Dougherty, T.J.; Gomer, C.J.; Henderson, B.W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic therapy. J. Natl.
Cancer Inst. 1998, 90, 889–905. [CrossRef] [PubMed]
17. Konopka, K.; Goslinski, T. Photodynamic therapy in dentistry. J. Dent. Res. 2007, 86, 694–707. [CrossRef]
18. Silva, M.; Paulo, M.; Cardoso, M.; Martins, M.; Noites, R. The use of systemic antibiotics in endodontics: A cross-sectional study.
J. Port. Estomatol. Med. Dent. Cir. Maxilofac. 2017, 58, 205–2011. [CrossRef]
19. Mainjot, A.; D’Hoore, W.; Vanheusden, A.; Van Nieuwenhuysen, J.P. Antibiotic prescribing in dental practice in Belgium. Int.
Endod. J. 2009, 42, 1112–1117. [CrossRef] [PubMed]
20. Rodriguez-Núñez, A.; Cisneros-Cabello, R.; Velasco-Ortega, E.; Llamas-Carreras, J.M.; Tórres-Lagares, D.; Segura-Egea, J.J.
Antibiotic use by members of the Spanish Endodontic Society. J. Endod. 2009, 35, 1198–1203. [CrossRef]
Antibiotics 2021, 10, 1106 10 of 11
21. Dormoy, J.; Vuillemin, M.O.; Rossi, S.; Boivin, J.M.; Guillet, J. Perceptions of Antibiotic Use and Resistance: Are Antibiotics the
Dentists’ Anxiolytics? Antibiotics 2021, 10, 735. [CrossRef] [PubMed]
22. Sedgley, C.M.; Lee, E.H.; Martin, M.J.; Flannagan, S.E. Antibiotic resistance gene transfer between Streptococcus gordonii and
Enterococcus faecalis in root canals of teeth ex vivo. J. Endod. 2008, 34, 570–574. [CrossRef] [PubMed]
23. Kuriyama, T.; Williams, D.W.; Yanagisawa, M.; Iwahara, K.; Shimizu, C.; Nakagawa, K.; Yamamoto, E.; Karasawa, T. Antimicrobial
susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics. Oral. Microbiol. Immunol.
2007, 22, 285–288. [CrossRef]
24. Dahlén, G.; Samuelsson, W.; Molander, A.; Reit, C. Identification and antimicrobial susceptibility of enterococci isolated from the
root canal. Oral. Microbiol. Immunol. 2000, 15, 309–312. [CrossRef]
25. Jungermann, G.B.; Burns, K.; Nandakumar, R.; Tolba, M.; Venezia, R.A.; Fouad, A.F. Antibiotic resistance in primary and persistent
endodontic infections. J. Endod. 2011, 37, 1337–1344. [CrossRef]
26. Mohammadi, Z.; Jafarzadeh, H.; Shalavi, S.; Yaripour, S.; Sharifi, F.; Kinoshita, J.I. A Review on Triple Antibiotic Paste as a
Suitable Material Used in Regenerative Endodontics. Iran. Endod. J. 2018, 13, 1–6.
27. Camacho-Alonso, F.; Salmerón-Lozano, P.; Martínez-Beneyto, Y. Effects of photodynamic therapy, 2% chlorhexidine, triantibiotic
mixture, propolis and ozone on root canals experimentally infected with Enterococcus faecalis: An in vitro study. Odontology
2017, 105, 338–346. [CrossRef]
28. Gajdács, M.; Spengler, G.; Urbán, E. Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik’s Cube
of Clinical Microbiology? Antibiotics 2017, 6, 25. [CrossRef] [PubMed]
29. Meire, M.A.; De Prijck, K.; Coenye, T.; Nelis, H.J.; De Moor, R.J. Effectiveness of different laser systems to kill Enterococcus faecalis
in aqueous suspension and in an infected tooth model. Int. Endod. J. 2009, 42, 351–359. [CrossRef]
30. Pourhajibagher, M.; Bahador, A. An in vivo evaluation of microbial diversity before and after the photo-activated disinfection in
primary endodontic infections: Traditional phenotypic and molecular approaches. Photodiagn. Photodyn. Ther. 2018, 22, 19–25.
[CrossRef]
31. Kosarieh, E.; Khavas, S.S.; Rahimi, A.; Chiniforush, N.; Gutknecht, N. The comparison of penetration depth of two different
photosensitizers in root canals with and without smear layer: An in vitro study. Photodiagn. Photodyn. Ther. 2016, 13, 10–14.
[CrossRef] [PubMed]
32. Giusti, J.S.; Santos-Pinto, L.; Pizzolito, A.C.; Helmerson, K.; Carvalho-Filho, E.; Kurachi, C.; Bagnato, V.S. Antimicrobial
photodynamic action on dentin using a light-emitting diode light source. Photomed. Laser Surg. 2008, 26, 281–287. [CrossRef]
[PubMed]
33. Nunes, M.R.; Mello, I.; Franco, G.C.; de Medeiros, J.M.; Dos Santos, S.S.; Habitante, S.M. Effectiveness of photodynamic therapy
against Enterococcus faecalis, with and without the use of an intracanal optical fiber: An in vitro study. Photomed. Laser Surg. 2011,
29, 803–808. [CrossRef] [PubMed]
34. Foschi, F.; Fontana, C.R.; Ruggiero, K.; Riahi, R.; Vera, A.; Doukas, A.G. Photodynamic inactivation of Enterococcus faecalis in
dental root canals in vitro. Lasers Surg. Med. 2007, 39, 782–787. [CrossRef] [PubMed]
35. Garcez, A.S.; Nuñez, S.C.; Hamblin, M.R.; Ribeiro, M.S. Antimicrobial effects of photodynamic therapy on patients with necrotic
pulps and periapical lesion. J. Endod. 2008, 34, 138–142. [CrossRef]
36. Garcez, A.S.; Hamblin, M.R. Methylene blue and hydrogen peroxide for photodynamic inactivation in root canal—A new protocol
for use in endodontics. Eur. Endod. J. 2017, 2, 29. [CrossRef]
37. Sjogren, U.; Figdor, D.; Persson, S.; Sundqvist, G. Influence of infection at the time of root filling on the outcome of endodontic
treatment of teeth with apical periodontitis. Int. Endod. J. 1997, 30, 297–306. [CrossRef] [PubMed]
38. Giuliani, F.; Martinelli, M.; Cocchi, A.; Arbia, D.; Fantetti, L.; Roncucci, G. In vitro resistance selection studies of RLP068/Cl, a
new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy. Antimicrob. Agents Chemother. 2010, 54, 637–642.
[CrossRef]
39. Lauro, F.M.; Pretto, P.; Covolo, L.; Jori, G.; Bertoloni, G. Photoinactivation of bacterial strains involved in periodontal diseases
sensitized by porphycene-polylysine conjugates. Photochem. Photobiol. Sci. 2002, 1, 468–470. [CrossRef]
40. López-Jiménez, L.; Fusté, E.; Martínez-Garriga, B.; Arnabat-Domínguez, J.; Vinuesa, T.; Viñas, M. Effects of photodynamic therapy
on Enterococcus faecalis biofilms. Lasers Med. Sci. 2015, 30, 1519–1526. [CrossRef] [PubMed]
41. Pagonis, T.C.; Chen, J.; Fontana, C.R.; Devalapally, H.; Ruggiero, K.; Song, X.; Foschi, F.; Dunham, J.; Skobe, Z.; Yamazaki, H.; et al.
Nanoparticle-based endodontic antimicrobial photodynamic therapy. J. Endod. 2010, 36, 322–328. [CrossRef]
42. Shrestha, A.; Kishen, A. The effect of tissue inhibitors on the antibacterial activity of chitosan nanoparticles and photodynamic
therapy. J. Endod. 2012, 38, 1275–1278. [CrossRef]
43. Afkhami, F.; Akbari, S.; Chiniforush, N. Entrococcus faecalis elimination in root canals using silver nanoparticles, photodynamic
therapy, diode laser, or laser-activated nanoparticles: An in vitro study. J. Endod. 2017, 43, 279–282. [CrossRef]
44. Cieplik, F.; Tabenski, L.; Buchalla, W.; Maisch, T. Antimicrobial photodynamic therapy for inactivation of biofilms formed by oral
key pathogens. Front. Microbiol. 2014, 5, 405. [CrossRef] [PubMed]
45. Ng, R.; Singh, F.; Papamanou, D.A.; Song, X.; Patel, C.; Holewa, C.; Patel, N.; Klepac-Ceraj, V.; Fontana, C.R.; Kent, R.; et al.
Endodontic photodynamic therapy ex vivo. J. Endod. 2011, 37, 217–222. [CrossRef] [PubMed]
Antibiotics 2021, 10, 1106 11 of 11
46. Hoedke, D.; Enseleit, C.; Gruner, D.; Dommisch, H.; Schlafer, S.; Dige, I.; Bitter, K. Effect of photodynamic therapy in combination
with various irrigation protocols on an endodontic multispecies biofilm ex vivo. Int. Endod. J. 2018, 51 (Suppl. 1), e23–e34.
[CrossRef]
47. Garcez, A.S.; Nuñez, S.C.; Hamblim, M.R.; Suzuki, H.; Ribeiro, M.S. Photodynamic therapy associated with conventional
endodontic treatment in patients with antibiotic-resistant microflora: A preliminary report. J. Endod. 2010, 36, 1463–1466.
[CrossRef] [PubMed]
48. Zorita-García, M.; Alonso-Ezpeleta, L.Ó.; Cobo, M.; Del Campo, R.; Rico-Romano, C.; Mena-Álvarez, J.; Zubizarreta-Macho,
Á. Photodynamic therapy in endodontic root canal treatment significantly increases bacterial clearance, preventing apical
periodontitis. Quintessence Int. 2019, 50, 782–789. [PubMed]
49. Garcez, A.S.; Neto, J.G.A.; Sellera, D.P.; Fregnani, E. Effects of antimicrobial photodynamic therapy and surgical endodontic
treatment on the bacterial load reduction and periapical lesion healing. Three years follow up. Photodiagn. Photodyn. Ther. 2015,
12, 575–580. [CrossRef] [PubMed]
50. Vieira, G.C.S.; Antunes, H.S.; Pérez, A.R.; Gonçalves, L.S.; Antunes, F.E.; Siqueira, J.F., Jr.; Rôças, I.N. Molecular Analysis of the
Antibacterial Effects of Photodynamic Therapy in Endodontic Surgery: A Case Series. J. Endod. 2018, 44, 1593–1597. [CrossRef]
[PubMed]
51. Abu Hasna, A.; Pereira Santos, D.; Gavlik de Oliveira, T.R.; Pinto, A.B.A.; Pucci, C.R.; Lage-Marques, J.L. Apicoectomy of
Perforated Root Canal Using Bioceramic Cement and Photodynamic Therapy. Int. J. Dent. 2020, 2020, 6677588. [CrossRef]
52. Moreira, M.S.; de Freitas Archilla, J.R.; Lascala, C.A.; Ramalho, K.M.; Gutknecht, N.; Marques, M.M. Post-Treatment Apical
Periodontitis Successfully Treated with Antimicrobial Photodynamic Therapy Via Sinus Tract and Laser Phototherapy: Report of
Two Cases. Photomed. Laser Surg. 2015, 33, 524–528. [CrossRef] [PubMed]
53. De Miranda, R.G.; Colombo, A.P.V. Clinical and microbiological effectiveness of photodynamic therapy on primary endodontic
infections: A 6-months randomized clinical trial. Clin. Oral. Investig. 2018, 22, 1751–1761. [CrossRef] [PubMed]
54. Conejero, M.J.; Almenar, A.; Forner, L.; Sanz, J.L.; Llena, C. Retrospective clinical evaluation of root canal treatment with or
without photodynamic therapy for necrotic teeth and teeth subjected to retreatment. J. Oral. Sci. 2021, 63, 163–166. [CrossRef]
[PubMed]
55. Rabello, D.G.D.; Corazza, B.J.M.; Ferreira, L.L.; Santamaria, M.P.; Gomes, A.P.M.; Martinho, F.C. Does supplemental photodynamic
therapy optimize the disinfection of bacteria and endotoxins in one-visit and two-visit root canal therapy? A randomized clinical
trial. Photodiagn. Photodyn. Ther. 2017, 19, 205–211. [CrossRef]
56. Asnaashari, M.; Ashraf, H.; Rahmati, A.; Amini, N. A comparison between effect of photodynamic therapy by LED and calcium
hydroxide therapy for root canal disinfection against Enterococcus faecalis: A randomized controlled trial. Photodiagn. Photodyn.
Ther. 2017, 17, 226–232. [CrossRef]
